Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,838,745
  • Shares Outstanding, K 61,312
  • Annual Sales, $ 376,570 K
  • Annual Income, $ -77,670 K
  • EBIT $ -135 M
  • EBITDA $ -110 M
  • 60-Month Beta 2.20
  • Price/Sales 10.08
  • Price/Cash Flow N/A
  • Price/Book 8.32

Options Overview Details

View History
  • Implied Volatility 97.92% (-7.14%)
  • Historical Volatility 76.10%
  • IV Percentile 91%
  • IV Rank 67.61%
  • IV High 117.20% on 11/20/25
  • IV Low 57.69% on 08/12/25
  • Expected Move (DTE 23) 5.78 (9.06%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 389
  • Volume Avg (30-Day) 311
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 3,259
  • Open Int (30-Day) 5,817
  • Expected Range 58.05 to 69.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.54
  • Number of Estimates 2
  • High Estimate $-0.46
  • Low Estimate $-0.62
  • Prior Year $-0.66
  • Growth Rate Est. (year over year) +18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.68 +50.09%
on 03/30/26
65.81 -2.66%
on 04/22/26
+21.99 (+52.27%)
since 03/20/26
3-Month
39.66 +61.52%
on 01/30/26
65.81 -2.66%
on 04/22/26
+18.91 (+41.88%)
since 01/22/26
52-Week
23.30 +174.94%
on 11/14/25
65.81 -2.66%
on 04/22/26
+27.12 (+73.42%)
since 04/22/25

Most Recent Stories

More News
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Company to host conference call at 8:00 AM ET Investor Day Scheduled for May 21, 2026

TWST : 64.06 (+2.32%)
Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of...

TWST : 64.06 (+2.32%)
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

B-Body ® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics ...

TWST : 64.06 (+2.32%)
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

Twist TrueAmp Library Preparation Kit with in-house developed enzymes including new Twist TrueAmp Polymerase Twist PCR-Free WGS Library Preparation Kit designed to meet the needs of the growing...

TWST : 64.06 (+2.32%)
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total...

TWST : 64.06 (+2.32%)
Twist Bioscience: Fiscal Q1 Earnings Snapshot

Twist Bioscience: Fiscal Q1 Earnings Snapshot

TWST : 64.06 (+2.32%)
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December...

TWST : 64.06 (+2.32%)
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?

Cathie Wood bets on Broadcom while shorting major market names in a week of activity.

BLSH : 42.94 (+2.41%)
ARKX : 33.84 (+1.41%)
NFLX : 93.26 (+0.73%)
META : 676.11 (+1.09%)
ROKU : 117.47 (+2.94%)
TXG : 22.56 (-1.78%)
GTLB : 22.03 (-0.54%)
AVGO : 415.54 (+3.32%)
TWST : 64.06 (+2.32%)
ILMN : 130.43 (-1.17%)
CRCL : 104.03 (+8.34%)
WRD : 8.15 (+0.62%)
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025....

TWST : 64.06 (+2.32%)
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the J.P....

TWST : 64.06 (+2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 67.41
2nd Resistance Point 66.25
1st Resistance Point 64.43
Last Price 64.06
1st Support Level 61.46
2nd Support Level 60.30
3rd Support Level 58.48

See More

52-Week High 65.81
Last Price 64.06
Fibonacci 61.8% 49.57
Fibonacci 50% 44.56
Fibonacci 38.2% 39.54
52-Week Low 23.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.